Featured Research

from universities, journals, and other organizations

Combined Hormone-Replacement Therapy May Boost Incidence Of Rare Form Of Breast Cancer

Date:
June 2, 2000
Source:
Fred Hutchinson Cancer Research Center
Summary:
The incidence of a rare form of breast cancer, called lobular carcinoma, is on the rise in postmenopausal women nationwide, and this increase may be associated with the widespread use of combined hormone-replacement therapy, according to researchers at the Fred Hutchinson Cancer Research Center in Seattle.

The incidence of a rare form of breast cancer, called lobular carcinoma, is on the rise in postmenopausal women nationwide, and this increase may be associated with the widespread use of combined hormone-replacement therapy, according to researchers at the Fred Hutchinson Cancer Research Center in Seattle.

These findings are reported today in a pair of papers in the journal CANCER. The lead author of both papers is Christopher Li, M.D., a postdoctoral fellow in the Hutchinson Center's Public Health Sciences Division. Researchers from the University of Washington collaborated on one of the studies. Lobular breast cancer, which involves the lobules -- chambers in the breast that contain small milk-producing glands -- accounts for only 5 percent to 10 percent of all invasive breast cancer cases. The most common form of breast cancer, representing up to 85 percent of cases, is ductal carcinoma, which involves the complex network of milk ducts that distribute milk from the lobules through the breast and into the nipple.

While much rarer than ductal breast cancer, lobular carcinoma appears to be on the rise in postmenopausal women, particularly among those who take combination hormone therapy (progestin and estrogen).

In one paper, Li and colleagues at the Hutchinson Center report a 2.6-fold increase in the incidence of lobular breast cancer among postmenopausal women who took combined hormone-replacement therapy for six months or more, as compared to those who took no hormones. This study involved nearly 1,000 Seattle-area women (half with breast cancer, half without).

In the other paper, Li and colleagues at the Hutchinson Center and UW report a significant increase in lobular breast cancer among postmenopausal women nationwide. For this study, the researchers looked at data from the Surveillance, Epidemiology and End Results program, or SEER, a national cancer registry operated by the National Cancer Institute. In analyzing data from 1977 to 1995, the researchers found a greater than 70 percent increase in lobular cancer in women registered at six of nine SEER data-collection sites. In comparison, the increase in ductal carcinoma was less than 40 percent among cases registered at six of the nine SEER sites. This study population included more than 120 million women nationwide.

"Although preliminary, our studies suggest that the incidence of lobular breast cancer is increasing nationwide and that the use of postmenopausal hormone-replacement therapy, specifically the use of combined estrogen plus progestin preparations, may be contributing to this increase," Li says. "However, future studies are required to confirm these findings, and it is important to note that lobular tumors represent only 5 percent to 10 percent of all breast carcinomas."

Both studies were funded by the National Cancer Institute.


Story Source:

The above story is based on materials provided by Fred Hutchinson Cancer Research Center. Note: Materials may be edited for content and length.


Cite This Page:

Fred Hutchinson Cancer Research Center. "Combined Hormone-Replacement Therapy May Boost Incidence Of Rare Form Of Breast Cancer." ScienceDaily. ScienceDaily, 2 June 2000. <www.sciencedaily.com/releases/2000/06/000602073904.htm>.
Fred Hutchinson Cancer Research Center. (2000, June 2). Combined Hormone-Replacement Therapy May Boost Incidence Of Rare Form Of Breast Cancer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2000/06/000602073904.htm
Fred Hutchinson Cancer Research Center. "Combined Hormone-Replacement Therapy May Boost Incidence Of Rare Form Of Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/06/000602073904.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com
Attacking Superbugs

Attacking Superbugs

Ivanhoe (Oct. 1, 2014) Two weapons hospitals can use to attack superbugs. Scientists in Ireland created a new gel resistant to superbugs, and a robot that can disinfect a room in minutes. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins